Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Haloperidol MeSH Descriptor Data 2025


MeSH Heading
Haloperidol
Tree Number(s)
D02.522.352.506
Unique ID
D006220
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D006220
Scope Note
A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
Entry Term(s)
Haldol
Pharm Action
Antiemetics
Antipsychotic Agents
Dopamine Antagonists
Anti-Dyskinesia Agents
Registry Numbers
J6292F8L3D
0
Related Numbers
52-86-8
CAS Type 1 Name
1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-
NLM Classification #
QV 77.9
Date Established
1966/01/01
Date of Entry
1999/01/01
Revision Date
2013/07/08
Haloperidol Preferred
Haldol Narrower
page delivered in 0.138s